Last reviewed · How we verify

Morphine hydrochloride, Spinal

South Carelia Central Hospital · FDA-approved active Small molecule

Morphine hydrochloride, Spinal is a Opioid agonist Small molecule drug developed by South Carelia Central Hospital. It is currently FDA-approved for Severe chronic pain (spinal administration), Cancer pain (intrathecal delivery).

Morphine hydrochloride binds to opioid receptors in the spinal cord to block pain signal transmission.

Morphine hydrochloride binds to opioid receptors in the spinal cord to block pain signal transmission. Used for Chronic pain management via intrathecal administration, Cancer pain, Post-operative pain.

At a glance

Generic nameMorphine hydrochloride, Spinal
SponsorSouth Carelia Central Hospital
Drug classOpioid agonist
TargetMu-opioid receptor (μ-OR)
ModalitySmall molecule
Therapeutic areaPain management
PhaseFDA-approved

Mechanism of action

When administered intrathecally (into the spinal fluid), morphine acts on mu-opioid receptors located on dorsal horn neurons and other pain-processing neurons in the spinal cord. This binding inhibits the release of neurotransmitters involved in pain signaling and hyperpolarizes neurons, effectively reducing pain perception at the spinal level with lower systemic doses than oral or parenteral administration.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Morphine hydrochloride, Spinal

What is Morphine hydrochloride, Spinal?

Morphine hydrochloride, Spinal is a Opioid agonist drug developed by South Carelia Central Hospital, indicated for Severe chronic pain (spinal administration), Cancer pain (intrathecal delivery).

How does Morphine hydrochloride, Spinal work?

Morphine hydrochloride binds to opioid receptors in the spinal cord to block pain signal transmission.

What is Morphine hydrochloride, Spinal used for?

Morphine hydrochloride, Spinal is indicated for Severe chronic pain (spinal administration), Cancer pain (intrathecal delivery).

Who makes Morphine hydrochloride, Spinal?

Morphine hydrochloride, Spinal is developed and marketed by South Carelia Central Hospital (see full South Carelia Central Hospital pipeline at /company/south-carelia-central-hospital).

What drug class is Morphine hydrochloride, Spinal in?

Morphine hydrochloride, Spinal belongs to the Opioid agonist class. See all Opioid agonist drugs at /class/opioid-agonist.

What development phase is Morphine hydrochloride, Spinal in?

Morphine hydrochloride, Spinal is FDA-approved (marketed).

What are the side effects of Morphine hydrochloride, Spinal?

Common side effects of Morphine hydrochloride, Spinal include Respiratory depression, Pruritus, Nausea and vomiting, Urinary retention, Hypotension, Headache.

What does Morphine hydrochloride, Spinal target?

Morphine hydrochloride, Spinal targets Mu-opioid receptor (μ-OR) and is a Opioid agonist.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing